109 related articles for article (PubMed ID: 38394487)
21.
Kuang W; Wang X; Ding J; Li J; Ji M; Chen W; Wang L; Yang P
Front Immunol; 2022; 13():805311. PubMed ID: 35154122
[TBL] [Abstract][Full Text] [Related]
22. AMP‑activated protein kinase family member 5 is an independent prognostic indicator of pancreatic adenocarcinoma: A study based on The Cancer Genome Atlas.
Xu H; Mao J; Yang X; Chen F; Song Z; Fei J; Chen W; Zhong Z; Wang X
Mol Med Rep; 2020 Nov; 22(5):4329-4339. PubMed ID: 33000197
[TBL] [Abstract][Full Text] [Related]
23. Identification of differentially expressed genes in pancreatic ductal adenocarcinoma and normal pancreatic tissues based on microarray datasets.
Liu L; Wang S; Cen C; Peng S; Chen Y; Li X; Diao N; Li Q; Ma L; Han P
Mol Med Rep; 2019 Aug; 20(2):1901-1914. PubMed ID: 31257501
[TBL] [Abstract][Full Text] [Related]
24. iTRAQ-based quantitative proteomics reveals myoferlin as a novel prognostic predictor in pancreatic adenocarcinoma.
Wang WS; Liu XH; Liu LX; Lou WH; Jin DY; Yang PY; Wang XL
J Proteomics; 2013 Oct; 91():453-65. PubMed ID: 23851313
[TBL] [Abstract][Full Text] [Related]
25. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.
Zhou J; Hui X; Mao Y; Fan L
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829
[TBL] [Abstract][Full Text] [Related]
26. BZW1 is a prognostic and immunological biomarker in pancreatic adenocarcinoma.
Luo A; Qiao N; Hu K; Xu H; Xie M; Jiang Y; Hu J
Medicine (Baltimore); 2024 Feb; 103(5):e37092. PubMed ID: 38306570
[TBL] [Abstract][Full Text] [Related]
27. LGI3 interacts with flotillin-1 to mediate APP trafficking and exosome formation.
Okabayashi S; Kimura N
Neuroreport; 2010 Jun; 21(9):606-10. PubMed ID: 20461023
[TBL] [Abstract][Full Text] [Related]
28. The Suppressive Effect of Leucine-Rich Glioma Inactivated 3 (LGI3) Peptide on Impaired Skin Barrier Function in a Murine Model Atopic Dermatitis.
Kim US; Park JW; Park ES; Bang JS; Jung TW; Kim DS; Abd El-Aty AM; Lee JH; Jeong JH
Pharmaceutics; 2020 Aug; 12(8):. PubMed ID: 32785038
[TBL] [Abstract][Full Text] [Related]
29. Identification of novel human neuronal leucine-rich repeat (hNLRR) family genes and inverse association of expression of Nbla10449/hNLRR-1 and Nbla10677/hNLRR-3 with the prognosis of primary neuroblastomas.
Hamano S; Ohira M; Isogai E; Nakada K; Nakagawara A
Int J Oncol; 2004 Jun; 24(6):1457-66. PubMed ID: 15138588
[TBL] [Abstract][Full Text] [Related]
30. A 6‑gene risk score system constructed for predicting the clinical prognosis of pancreatic adenocarcinoma patients.
Liu Y; Zhu D; Xing H; Hou Y; Sun Y
Oncol Rep; 2019 Mar; 41(3):1521-1530. PubMed ID: 30747226
[TBL] [Abstract][Full Text] [Related]
31. Ultraviolet B-induced LGI3 secretion protects human keratinocytes.
Lee SH; Jeong YM; Kim SY; Jeong HS; Park KC; Baek KJ; Kwon NS; Yun HY; Kim DS
Exp Dermatol; 2012 Sep; 21(9):716-8. PubMed ID: 22741557
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Value and the Immune Microenvironment-associated Role of
Song Y; Wang Y; Yu T; He Y; Wang C; Wang F; Zhou Y
Anticancer Res; 2023 Dec; 43(12):5393-5408. PubMed ID: 38030175
[TBL] [Abstract][Full Text] [Related]
33. β6-Integrin Serves as a Potential Serum Marker for Diagnosis and Prognosis of Pancreatic Adenocarcinoma.
Lenggenhager D; Bengs S; Fritsch R; Hussung S; Busenhart P; Endhardt K; Töpfer A; The FO; Bütikofer S; Gubler C; Scharl M; Morell B
Clin Transl Gastroenterol; 2021 Aug; 12(8):e00395. PubMed ID: 34388137
[TBL] [Abstract][Full Text] [Related]
34. Regional distribution of the leucine-rich glioma inactivated (LGI) gene family transcripts in the adult mouse brain.
Herranz-Pérez V; Olucha-Bordonau FE; Morante-Redolat JM; Pérez-Tur J
Brain Res; 2010 Jan; 1307():177-94. PubMed ID: 19833108
[TBL] [Abstract][Full Text] [Related]
35. Computational prediction and experimental validation associating FABP-1 and pancreatic adenocarcinoma with diabetes.
Sharaf RN; Butte AJ; Montgomery KD; Pai R; Dudley JT; Pasricha PJ
BMC Gastroenterol; 2011 Jan; 11():5. PubMed ID: 21251264
[TBL] [Abstract][Full Text] [Related]
36. A novel immune checkpoint score system for prognostic evaluation in pancreatic adenocarcinoma.
Chen Y; Lin X; Zou X; Qian Y; Liu Y; Wang R; Wang X; Yu X; Liu C; Cheng H
BMC Gastroenterol; 2023 Apr; 23(1):113. PubMed ID: 37024802
[TBL] [Abstract][Full Text] [Related]
37. High expression of LAMA3/AC245041.2 gene pair associated with KRAS mutation and poor survival in pancreatic adenocarcinoma: a comprehensive TCGA analysis.
Tian C; Li X; Ge C
Mol Med; 2021 Jun; 27(1):62. PubMed ID: 34134622
[TBL] [Abstract][Full Text] [Related]
38. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
[TBL] [Abstract][Full Text] [Related]
39. Leucine-rich glioma inactivated 3 is involved in amyloid beta peptide uptake by astrocytes and endocytosis itself.
Okabayashi S; Kimura N
Neuroreport; 2008 Aug; 19(12):1175-9. PubMed ID: 18628660
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Significance of KIF11 and KIF14 Expression in Pancreatic Adenocarcinoma.
Klimaszewska-Wiśniewska A; Neska-Długosz I; Buchholz K; Durślewicz J; Grzanka D; Kasperska A; Antosik P; Zabrzyński J; Grzanka A; Gagat M
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34208606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]